Literature DB >> 2541666

Clinical manifestations of human parvovirus B19 in adults.

A D Woolf1, G V Campion, A Chishick, S Wise, B J Cohen, P T Klouda, O Caul, P A Dieppe.   

Abstract

Human parvovirus B19 has been associated with various clinical effects in a number of uncontrolled reports. To define the usual manifestations of B19 infection in adults and the factors that influence them we present a clinicoepidemiological study of an outbreak of B19 infection centered on a junior school. Four hundred fifty-three of 475 adults in this community were interviewed and blood was obtained for serological diagnosis. Fifty-four cases of recent infection were identified and were HLA typed. Fourteen of the cases were asymptomatic; 32 had an influenzalike illness; 23 a rash; and 26 an acute-onset polyarthropathy that was more common in women and lasted for up to 7 months. HLA-A, -B, and -C antigen frequencies were similar to a local control population and showed no association with symptoms except that HLA-DR1 was absent in those with persistent arthropathy.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2541666

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  44 in total

Review 1.  Pathogenesis of human parvovirus B19 in rheumatic disease.

Authors:  J R Kerr
Journal:  Ann Rheum Dis       Date:  2000-09       Impact factor: 19.103

2.  Impaired gamma interferon responses against parvovirus B19 by recently infected children.

Authors:  A Corcoran; S Doyle; D Waldron; A Nicholson; B P Mahon
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

Review 3.  Parvovirus B19 infection in human pregnancy.

Authors:  R F Lamont; J D Sobel; E Vaisbuch; J P Kusanovic; S Mazaki-Tovi; S K Kim; N Uldbjerg; R Romero
Journal:  BJOG       Date:  2010-10-13       Impact factor: 6.531

4.  Human parvovirus B19 viraemia is associated with neither IgM positivity nor anaemia in patients with rheumatic diseases.

Authors:  Y Munakata; T Saito
Journal:  Ann Rheum Dis       Date:  2006-02       Impact factor: 19.103

5.  Detection of adeno-associated virus 2 and parvovirus B19 in the human dorsolateral prefrontal cortex.

Authors:  Jacqueline A Hobbs
Journal:  J Neurovirol       Date:  2006-06       Impact factor: 2.643

6.  Parvoviral infection with systemic impact and renal consequences.

Authors:  Filipe Santos Mira; Daniel Marques; Vítor Sousa; Célia Nogueira; Rui Garcia; Rui Alves
Journal:  BMJ Case Rep       Date:  2019-06-08

7.  The relationship between arthritis and human parvovirus B19 infection.

Authors:  R Caliskan; S Masatlioglu; M Aslan; S Altun; S Saribas; S Ergin; E Uckan; V Koksal; V Oz; K Altas; I Fresko; B Kocazeybek
Journal:  Rheumatol Int       Date:  2004-08-20       Impact factor: 2.631

Review 8.  Parvovirus B19 infection.

Authors:  J R Kerr
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-01       Impact factor: 3.267

Review 9.  Recent insights into the role of autoimmunity in idiopathic dilated cardiomyopathy.

Authors:  Jason M Lappé; Clara M Pelfrey; W H Wilson Tang
Journal:  J Card Fail       Date:  2008-05-27       Impact factor: 5.712

Review 10.  Human parvovirus B19.

Authors:  Erik D Heegaard; Kevin E Brown
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.